Shamoun Fadi E, Craner Ryan C, Seggern Rita Von, Makar Gerges, Ramakrishna Harish
Mayo Clinic, Department of Anesthesiology, Arizona, USA.
Ann Card Anaesth. 2015 Oct-Dec;18(4):528-36. doi: 10.4103/0971-9784.166462.
Mitral valve disease is common in the United States and around the world, and if left untreated, increases cardiovascular morbidity and mortality. Mitral valve repair is technically more demanding than mitral valve replacement. Mitral valve repair should be considered the first line of treatment for mitral regurgitation in younger patients, mitral valve prolapse, annular dilatation, and with structural damage to the valve. Several minimally invasive percutaneous treatment options for mitral valve repair are available that are not restricted to conventional surgical approaches, and may be better received by patients. A useful classification system of these approaches proposed by Chiam and Ruiz is based on anatomic targets and device action upon the leaflets, annulus, chordae, and left ventricle. Future directions of minimally invasive techniques will include improving the safety profile through patient selection and risk stratification, improvement of current imaging and techniques, and multidisciplinary education.
二尖瓣疾病在美国及全球都很常见,若不治疗,会增加心血管疾病的发病率和死亡率。二尖瓣修复在技术上比二尖瓣置换要求更高。对于年轻患者的二尖瓣反流、二尖瓣脱垂、瓣环扩张以及瓣膜结构损伤,二尖瓣修复应被视为一线治疗方法。目前有几种用于二尖瓣修复的微创经皮治疗方案,这些方案不限于传统手术方法,可能更容易被患者接受。Chiam和Ruiz提出的这些方法的一个有用分类系统是基于解剖靶点以及器械对瓣叶、瓣环、腱索和左心室的作用。微创技术的未来发展方向将包括通过患者选择和风险分层提高安全性、改进当前的成像和技术,以及开展多学科教育。